Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Objective: To assess the effectiveness and safety of antiplatelet drugs for prevention of pre-eclampsia and its consequences. Design: Systematic review. Data sources: Register of trials maintained by Cochrane Pregnancy and Childbirth Group, Cochrane Controlled Trials Register, and Embase. Included studies: Randomised trials involving women at risk of pre-eclampsia, and its complications, allocated to antiplatelet drug(s) versus placebo or no antiplatelet drug. Main outcomes measures: Pre-eclampsia, preterm birth, fetal or neonatal death, and small for gestational age baby. Studies were assessed for quality of concealment of allocation and losses to follow up. Results: 39 trials (30 563 women) were included, and 45 trials (>3000 women) excluded. Use of antiplatelet drugs was associated with a 15% reduction in the risk of pre-eclampsia (32 trials, 29 331 women; relative risk 0.85, 95% confidence interval 0.78 to 0.92; number needed to treat 100, 59 to 167). There was also an 8% reduction in the risk of preterm birth (23 trials, 28 268 women; 0.92, 0.88 to 0.97; 72, 44 to 200), and a 14% reduction in the risk of fetal or neonatal death (30 trials, 30 093 women; 0.86, 0.75 to 0.98; 250, 125 to >10 000) for women allocated antiplatelet drugs. Small for gestational age babies were reported in 25 trials (20 349 women), with no overall difference between the groups (relative risk 0.92, 0.84 to 1.01). There were no significant differences in other measures of outcome. Conclusions: Antiplatelet drugs, largely low dose aspirin, have small to moderate benefits when used for prevention of pre-eclampsia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Antiplatelet agents for preventing and treating pre-eclampsia
Knight, M., Duley, L., Henderson-Smart, D., & King, J. (2000) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000492 · Cited by 112
Self-citationRetractedBias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
National High Blood Pressure Education Program Working Group report on hypertension in diabetes
(1994) · Hypertension · doi:10.1161/01.hyp.23.2.145 · Cited by 1,004
DULEY, L. (1992) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1992.tb13818.x · Cited by 527
Self-citationEgger, M., & Smith, G. D. (1995) · BMJ · doi:10.1136/bmj.310.6982.752 · Cited by 508
Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1991-1993
Stationery Office (1996) · HMSO eBooks · Cited by 477
(1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90653-o · Cited by 438
Cochrane Collaboration Handbook
Mulrow, C. (1996) · Medical Entomology and Zoology · Cited by 403
Working Group Report on High Blood Pressure in Pregnancy
Moser, M. (2001) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2001.00458.x · Cited by 246
A Meta-analysis of Low-Dose Aspirin for the Prevention of Pregnancy-Induced Hypertensive Disease
Imperiale, T. F. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470020086038 · Cited by 231
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Williams, B., Poulter, N. R., Brown, M. J., Davis, M., McInnes, G. T., Potter, J. F., Sever, P. S., & McG Thom, S. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001683 · Cited by 1,272
Diagnosis and Management of Gestational Hypertension and Preeclampsia
Sibai, B. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(03)00475-7 · Cited by 1,146
Antiplatelet agents for preventing pre-eclampsia and its complications
Duley, L., Henderson-Smart, D. J., Meher, S., & King, J. F. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004659.pub2 · Cited by 1,016
Self-citationPatrono, C., Coller, B., Dalen, J. E., Fitz Gerald, G. A., Fuster, V., Gent, M., Hirsh, J., & Roth, G. (2001) · Chest · doi:10.1378/chest.119.1_suppl.39s · Cited by 963
Patrono, C., Baigent, C., Hirsh, J., & Roth, G. (2008) · Chest · doi:10.1378/chest.08-0672 · Cited by 748
Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2014) · Blood Pressure · doi:10.3109/08037051.2014.868629 · Cited by 739
Daskalopoulou, S. S., Rabi, D. M., Zarnke, K. B., Dasgupta, K., Nerenberg, K., Cloutier, L., Gelfer, M., Lamarre-Cliche, M., Milot, A., Bolli, P., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.016 · Cited by 684
Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy
Roberts, J. M., Pearson, G., Cutler, J., & Lindheimer, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000054981.03589.e9 · Cited by 677
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
Patrono, C., Coller, B., FitzGerald, G. A., Hirsh, J., & Roth, G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.234s · Cited by 671
Evaluation of diagnostic tests when there is no gold standard. A review of methods
Rutjes, A., Reitsma, J., Coomarasamy, A., Khan, K., & Bossuyt, P. (2007) · Health Technology Assessment · doi:10.3310/hta11500 · Cited by 524
Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy
Roberts, J. M., Pearson, G. D., Cutler, J. A., & Lindheimer, M. D. (2003) · Hypertension in Pregnancy · doi:10.1081/prg-120016792 · Cited by 436
Osungbade, K. O., & Ige, O. K. (2011) · Journal of Pregnancy · doi:10.1155/2011/481095 · Cited by 429
“Searches were also supplemented with recommendations from outside experts and reviews of bibliographies of other relevant articles and systematic reviews.”
MethodMancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Blood Pressure · doi:10.3109/08037051.2013.812549 · Cited by 426
Antiplatelet agents for preventing pre-eclampsia and its complications
Duley, L., Meher, S., Hunter, K. E., Seidler, A. L., & Askie, L. M. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004659.pub3 · Cited by 366
Self-citationTomimatsu, T., Mimura, K., Matsuzaki, S., Endo, M., Kumasawa, K., & Kimura, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174246 · Cited by 277
Meher, S., Duley, L., Hunter, K., & Askie, L. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.10.016 · Cited by 239
Self-citationREY, E., GARNEAU, P., DAVID, M., GAUTHIER, R., LEDUC, L., MICHON, N., MORIN, F., DEMERS, C., KAHN, S. R., MAGEE, L. A., et al. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03230.x · Cited by 222
Kupferminc, M. J. (2003) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-1-111 · Cited by 177
“Recently, the Cochrane Collaboration [136] reported a 15% reduction in the risk of preeclampsia (32 trials with 29,331 women; relative risk (RR) 0.85; 95% CI 0.78– 0.92) and a 14% reduction in fetal and/or neonatal death (30 trials with 30,093 women; RR 0.86 95% CI 0.75– 0.99).”
BackgroundInfluentialYu, C. K. H., Papageorghiou, A. T., Parra, M., Palma Dias, R., Nicolaides, K. H., & The Fetal Medicine Foundation Second Trimester Screening Group (2003) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.218 · Cited by 170
Lilford, R., & Stevens, A. J. (2002) · British journal of surgery · doi:10.1046/j.1365-2168.2002.01989.x · Cited by 31
Metadata
- Authors
- Duley, L., Henderson-Smart, D., Knight, M., & King, J.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2001-02-10
- Volume
- 322
- Issue
- 7282
- Pages
- 329-333
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2133479239
- Cited by
- 241
- References
- 24
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.